Spain· ES:80607
AMEKRIN 75 MG/1,5 ML CONCENTRADO Y DISOLVENTE PARA CONCENTRADO PARA SOLUCION PARA PERFUSION
A medicinal product containing amsacrina, registered in Spain by Eurocept International B.V..
Checked against AEMPS CIMA (Spain) on
Informational only — not a medical device.
The record
At a glance
AEMPS CIMA (Spain)- Active substance
- amsacrina
- Manufacturer
- Eurocept International B.V.
- Country
- Spain (ES)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- AEMPS CIMA (Spain)
- Last checked
- June 3, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Amsacrina in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomAmsidine 75mg/1.5ml concentrate and solvent for solution for infusion vialsEurocept International bv
- FinlandAmekrinEurocept International BV
- GermanyAmlyoEurocept International Bv
- NorwayAmlyoEurocept
- NetherlandsAmsalyo 75 mg poeder voor concentraat voor oplossing voor infusieEurocept International B.V.
- BelgiumAmsidine 75 mg/1.5 mlEurocept International
- SwedenAmsalyo 75 mg Pulver till koncentrat till infusionsvätska, lösningEurocept International B.V.
- FranceAMSALYO 75 mg, poudre pour solution pour perfusionEUROCEPT INTERNATIONAL (PAYS-BAS)
Authorised across Europe · EMA
The same active substance is authorised in 13 EEA countries. Names it is sold under:
- Austria · Amlyo
- Germany · Amlyo, Amsidyl
- Denmark · Amsalyo
- Finland · Amsalyo
- France · Amsalyo
- Croatia · Amlyo
- Ireland · Amsalyo
- Iceland · Amsalyo
- Italy · Amsalyo
- Luxembourg · Amsalyo
- Netherlands · Amsalyo
- Norway · Amsalyo
- Sweden · Amsalyo
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AEMPS CIMA (Spain). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/5c641fa9-017e-41e1-9770-8b7c647c8734 GET /v1/drugs/5c641fa9-017e-41e1-9770-8b7c647c8734?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cpresc": "Uso Hospitalario",
"estado": "{\"aut\":1564610400000,\"rev\":1735557903000}",
"nregistro": "80607",
"substance": "amsacrina"
}See everything about amsacrina.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.